BIOPORTO DIAGNOSTICS A/S: Financial statements 2013
CVR: 18645882
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
BIOPORTO DIAGNOSTICS A/S (CVR 18645882) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 16,625,213 and a net result of DKK -20,607,371 compared with DKK -15,105,000 the year before. That is a decrease of 6.9% compared with the year before. The profit margin was -124%. Equity in the 2013 report amounted to DKK -146,431,644.
- Revenue
- DKK 16,625,213
- Gross Profit
- DKK -1,168,969
- Profit/Loss
- DKK -20,607,371
- Equity
- DKK -146,431,644
- Total Assets
- DKK 19,726,698
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | 16.6 mio. | -1.2 mio. | -20.6 mio. | -146.4 mio. | - |
| 2012 | 17.9 mio. | 11.1 mio. | -15.1 mio. | -125.8 mio. | 20 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of July 18, 2013, Peter Mørch Eriksen has joined the board of directors of BIOPORTO DIAGNOSTICS A/S.
As of July 18, 2013, Thea Olesen has left the board of directors of BIOPORTO DIAGNOSTICS A/S.
As of July 18, 2013, Peter Mørch Eriksen is registered as adm. dir. of BIOPORTO DIAGNOSTICS A/S.
As of July 18, 2013, Thea Olesen has stepped down as adm. dir. of BIOPORTO DIAGNOSTICS A/S.
BIOPORTO DIAGNOSTICS A/S has published its annual report for 2012. Revenue came to DKK 17,858,000, and the net result was DKK -15,105,000.
As of May 30, 2013, Torben Arnth Nielsen has joined the board of directors of BIOPORTO DIAGNOSTICS A/S.
As of May 30, 2013, Lars Otto Uttenthal has left the board of directors of BIOPORTO DIAGNOSTICS A/S.
As of April 15, 2013, Thomas Magnussen has joined the board of directors of BIOPORTO DIAGNOSTICS A/S.
As of April 15, 2013, Knud Carsten Bernhard Lønfeldt has left the board of directors of BIOPORTO DIAGNOSTICS A/S.
About BIOPORTO DIAGNOSTICS A/S
BIOPORTO DIAGNOSTICS A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 1995. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ANTIBODYSHOP A/S and IMMUNOLEX ApS. The management consists of Carsten Buhl. The board consists of Gry Louise Husby Larsen (chair), Carsten Buhl and Klaus Juhl Wulff. The company is owned by BIOPORTO A/S. The company has 29 employees (2026). In 2025, the company reported revenue of DKK 40,286,970 and a net result of DKK -81,398,096 compared with DKK -110,908,377 the year before. Equity in the 2025 report amounted to DKK -837,580,713.